Santen Pharm CO ADR (SNPHY)

10.60
+0.04 (0.38%)
OP · Last Trade: Mar 23rd, 6:07 PM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors
SNPHY Stock Earnings: Santen Pharmaceutical Reported Results for Q4 2023investorplace.com
Santen Pharmaceutical just reported results for the fourth quarter of 2023.
Via InvestorPlace · May 17, 2024
Current Analysis: Santen Pharmaceuticaltalkmarkets.com
Santen Pharmaceutical Co Ltd is a drug manufacturing company that focuses on ophthalmic products. Over the past year, Santen's share price rose about 32% from $7.60 to $10.01 as of Thursday’s market close
Via Talk Markets · February 15, 2024